Clinical trials
- Submission status
- Open
- Submission deadline
Nature Communications is interested in publishing high-quality clinical research in all areas of medicine. In this call for papers, we are inviting submissions of papers reporting interventional trials - we will consider phase I to phase IV clinical trials - including those yielding negative results for which primary end-points were not met.
We are particularly interested in studies first reporting primary and secondary outcomes of interventional clinical trials, but we would also consider long-term follow-up of published trials.
All manuscripts will be considered according to our editorial policies for clinical research. Further information can be found in our recent editorial. Unfortunately, we cannot guarantee that any individual paper will be included in the desired collection.
The Collection is open for submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of Nature Communications more generally.
All submissions will be subject to the same peer review process and editorial processes as regular Nature Communications articles.
When submitting your manuscript to Nature Communications via our online submission system, please choose the appropriate Collection title from the drop-down menu on the submission form. Please be sure to express your interest in the Collection in your cover letter.
This Collection has not been supported by sponsorship.
